FIELD: medicine.
SUBSTANCE: lithium ascorbate is used in a therapeutic concentration of 0.11 mg/ml.
EFFECT: invention use enables to protect blood plasma proteins and lipids from ethanoldamaging action.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WHICH INCREASES ERYTHROCYTE RESISTANCE TO HAEMOLYSIS INDUCED BY ETHANOL | 2018 |
|
RU2699224C1 |
| MEDIATION, POSSESSING HAEMATOPROTACTING EFFECT | 2006 |
|
RU2351326C2 |
| METHOD FOR TREATMENT OF ALCOHOLISM | 1990 |
|
RU2007171C1 |
| METHOD FOR PREDICTING THE DURATION OF THERAPEUTIC REMISSION IN PATIENTS WITH ALCOHOLISM | 2021 |
|
RU2756613C1 |
| METHOD OF DIAGNOSING ALCOHOL-INDUCED HEART INJURY IN PATIENTS WITH SEVERE ETHANOLIC INTOXICATION | 2003 |
|
RU2264626C2 |
| AGENT FOR REDUCING COURSE RATE, DEVELOPMENT PROPHYLAXIS, PROPHYLAXIS FOR ARISING PATHOLOGICAL PROCESSES CAUSED BY ETHANOL USING AND/OR SUBSTANCES ELICITING ADDICTIVE POTENTIAL | 2003 |
|
RU2229291C9 |
| MEDICATION FOR REDUCING RATE OF PROGRESSING, PREVENTION OF DEVELOPMENT, PREVENTION OF ONSET OF PATHOLOGICAL PROCESSES INDUCED BY INTAKE OF ETHANOL AND/OR SUBSTANCES POSSESSING ADDICTIVE POTENTIAL | 2003 |
|
RU2423117C2 |
| METHOD OF ALCOHOLIC ABSTINENCE SYNDROME REDUCTION | 2006 |
|
RU2327474C1 |
| METHOD FOR PREDICTION OF COMORBID COURSE OF AFFECTIVE DISORDERS AND ALCOHOLISM BASED ON DETERMINATION OF BLOOD SERUM PROTEINS | 2021 |
|
RU2767699C1 |
| METHOD FOR MAKING ALCOHOLISM PATIENT REHABILITATION AT REMISSION CREATION STAGE | 2006 |
|
RU2318512C1 |
